Action Flash

The Educational Choice Changes In Michigan Due To The Hard Work Of Betsy DeVos

Betsy DeVos has been involved in politics for thirty years. She has been the leader in party organizations, campaigns and political action committees. She has searched for solutions to social problems and is active in nonprofit causes. She serves on numerous local and national charitable boards.

Betsy DeVos is an advocate for educational choice, voucher programs, educational savings accounts and tax credits. She has helped low income families in Grand Rapids provide their children with a safe atmosphere for their education. Ms. DeVos and her husband significantly support the Potter House because they believe in helping children achieve an education that will provide them with a good future. She founded a foundation that provided scholarships to families with low incomes in desperate need of the assistance. Follow Betsy DeVos on twitter.com

Betsy DeVos became involved in the movement for educational choice in the 1990’s with the American Education Reform Council and Children First America. She was working towards expanding educational choice with the use of tax credits and vouchers. She was involved in passing the first charter school bill in Michigan in 1993.

Betsy DeVos began a committee in Michigan for political action known as the Great Lakes Education Project. The purpose of the committee was the promotion of educational reform by expanding Michigan’s charter schools. She has educated potential legislators, helped get them elected and helped in the creation and passing of legislation to promote educational choice.

Betsy DeVos has proven herself as a leader, an advocate, an innovator and a disruptor. She has been one of the principle pioneers in politics, business and education in the fight to enact change, remove barriers and create positive environments where individuals can grow and thrive. She was formerly with the Windquest Group as their Chairman. The group is a private management and investment firm based out of Michigan with a diversified service portfolio and consumer product.

Betsy has been an active politician for well over 35 years and the Michigan Republican Party elected her as their chairman four times. She has held multiple roles in leadership with campaigns, political action committees and party organizations. Her current efforts are focused on the advancement of educational and school choice.

Betsy DeVos has remained active within her community. She was the former chair for The Philanthropy Roundtable and American Federation for Children board of directors. She has served on quite a few local and national boards including the Foundation for Excellence in Education, ArtPrize, the DeVos Institute for Arts Management located at the University of Maryland and the American Enterprise Institute. Visit dbdvfoundation.org to know more about their foundation.

Betsy DeVos attended and graduated from Holland Christian High School. She attended Calvin College in Grand Rapids, Michigan where she earned her Bachelor of Arts degree. Her husband is community activist, philanthropist and entrepreneur Dick DeVos. The couple has four children and five grandchildren.

How Dr. Rick Shinto Provides Affordable And Excellent Healthcare Plans

InnovaCare Health’s core value is to provide high-quality medical care to the people that buy their healthcare policies. Teamwork is also highly valued at this company which is an emphasis of its President and Chief Executive Officer, Dr. Rick Shinto. He has developed a team at InnovaCare Health that effectively communicates, both among itself and with their customers, as well as one that has great working relationships. They embody their mission statement which is to redefine the management of healthcare.

InnovaCare Health provides health insurance policies to the residents of Puerto Rico. They have two subsidiaries on this island, MMM Healthcare Inc. and PMC MediCare Choice Inc. Both healthcare programs, which are NCQA accredited, consistently have customer satisfaction rates that exceed 90%. In order to receive NCQA accreditation, Dr. Rick Shinto and his team had to exceed quality assurance standards. Contact details available at Manta.com.

Dr. Rick Shinto has been in the healthcare field for four decades. He has been both a physician and executive in the industry. Before joining InnovaCare Health Dr. Rick Shinto was the CEO of Aveta Inc. where he was awarded Entrepreneur of the Year by Ernst & Young. He also served Medical Management as a Vice President as well as Chief Medical Officer at Cal Optima Health Plan.

Dr. Rick Shinto earned his Bs. at the University of California and his M.D. at the State University of New York. He also holds an MBA which he earned at the University of Redlands. He has also been the author of several articles about clinical medicine and the healthcare field. It was as a physician the Dr. Rick Shinto started his professional career as. He worked as a pulmonologist and internist in Southern California. He transitioned into management after several years of directly treating patients.

Read more: https://www.bloomberg.com/research/stocks/private/snapshot.asp?privcapId=225431891

One of Dr. Rick Shinto’s goals at InnovaCare Health is to make obtaining medical care affordable for their clients in Puerto Rico. One of the ways they do this is by making use of innovative technology that helps to keep costs low while still delivering superb care. He also uses his industry experience and knowledge in order to come up with innovative ways of keeping the costs down.

Oncology According to Mikhail Blagosklonny

In a world where cancer is becoming the order of the day, people are in need of scientists like Mikhail Blagosklonny. He is defying all odds to study cancer and the different treatments. Mikhail is a scientist who has been involved with the study of cancer and aging.

Education background

Mikhail graduated with his Doctor of Medicine in internal medicine from the First Pavlov State Medical University. He later pursued his Ph.D. in experimental medicine and cardiology from the same University.

Learn more: https://www.ncbi.nlm.nih.gov/pubmed/?term=blagosklonny

Career

In 2002, Mikhail was appointed the associate professor of the New York Medical College. Soon after, he took on a position at the Ordway Research Institute as the senior scientist. In 2009, Mikhail left the organization to become a professor at the Roswell Park Cancer Institute. He later resigned from the position.

Apart from imparting knowledge to young people, Mikhail is involved in different research related to cancer and aging. His research interests revolve around the cancer therapies that can protect the cells from damage. Mikhail also studies the mechanisms of aging and the anti-aging drugs.

Blagosklonny is the editor-in-chief of three different journals which include; oncotarget which is a peer-reviewed medical journal that publishes research related to oncology, Aging also a peer-reviewed scientific journal, and Cell Cycle a peer-review journal that publishes research related to cell biology. Mikhail serves as a member of the editorial board of Cell Death and Differentiation.

As a research scientist, Mikhail has published over 270 papers in various journals. In all his publications, he has quoted over 25,000 citations. This has given him an h-index (author-level index) of 83. Visit ResearchGate.Net to learn more about Mikhail’s latest work.

TOR Signaling

Among his notable work, TOR Signaling has been the most successful. Mikhail has developed a hypothesis that seeks to understand the role of TOR Signaling in Aging and also cancer. He has also looked into the role of rapamycin, a drug that promotes life extension. According to Mikhail, people die because of the age-related diseases, however, by using Rapamycin they can slow down the age-related diseases. Mikhail states that with the elimination of the external causes of death, the main cause of death will be the post-aging syndrome.

The TOR Signaling has played an important role in treating cancer. Mikhail Blagosklonny research indicates that the over-activation of the TOR Signaling can lead to the development of tumors. In some of the common types of cancer like breast prostate, lung, brain, bladder, and melanoma, the mTOR Signaling activity is deregulated. It is, therefore, prudent for the constitutive activation to be practiced.

Research on the Effects of TOR Signaling has been done in other areas including the Central Nervous System, brain function (although more research is required), Alzheimer’s disease, and Autism.

Mikhail is an advocate for the use of Rapamycin in the life extension. Mikhail is also involved in the study of molecular biology and cellular in clinical investigations. Mikhail is involved in the study of tumor suppressors, oncogenesis, cell cycle, drug resistance, selective protection, mitosis, and apoptosis.

Blagosklonny is the author of aging hyperfunction theory.